全文获取类型
收费全文 | 4129篇 |
免费 | 98篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 226篇 |
妇产科学 | 81篇 |
基础医学 | 951篇 |
口腔科学 | 32篇 |
临床医学 | 242篇 |
内科学 | 1047篇 |
皮肤病学 | 48篇 |
神经病学 | 738篇 |
特种医学 | 43篇 |
外科学 | 206篇 |
综合类 | 178篇 |
预防医学 | 171篇 |
眼科学 | 70篇 |
药学 | 129篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 112篇 |
出版年
2023年 | 46篇 |
2022年 | 110篇 |
2021年 | 137篇 |
2020年 | 121篇 |
2019年 | 162篇 |
2018年 | 153篇 |
2017年 | 116篇 |
2016年 | 110篇 |
2015年 | 131篇 |
2014年 | 221篇 |
2013年 | 237篇 |
2012年 | 164篇 |
2011年 | 210篇 |
2010年 | 146篇 |
2009年 | 192篇 |
2008年 | 248篇 |
2007年 | 163篇 |
2006年 | 179篇 |
2005年 | 146篇 |
2004年 | 119篇 |
2003年 | 117篇 |
2002年 | 87篇 |
2001年 | 81篇 |
2000年 | 65篇 |
1999年 | 68篇 |
1998年 | 52篇 |
1997年 | 45篇 |
1996年 | 38篇 |
1995年 | 46篇 |
1994年 | 38篇 |
1993年 | 37篇 |
1992年 | 27篇 |
1991年 | 23篇 |
1990年 | 20篇 |
1989年 | 19篇 |
1988年 | 23篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 60篇 |
1984年 | 53篇 |
1983年 | 38篇 |
1982年 | 46篇 |
1981年 | 48篇 |
1980年 | 36篇 |
1979年 | 29篇 |
1978年 | 19篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1975年 | 11篇 |
1974年 | 14篇 |
排序方式: 共有4318条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
《Journal of Science and Medicine in Sport》2020,23(4):342-346
ObjectivesThe aim of this case control genetic association study was to explore whether two variants within the inducible nitric oxide synthase (iNOS) gene, rs2779249 (C/A) and rs2248814 (A/G), influenced the risk of Achilles tendinopathy in a British population.DesignCandidate gene, case control association study.MethodWe recruited 145 individuals diagnosed with Achilles tendon pathology and 132 asymptomatic controls. All participants were genotyped for the iNOS variants using qPCR and significant associations were discovered using a combination of Chi squared and ANOVA type analysis.ResultsThe CA genotype of the iNOS rs2779249 variant was protective and conformed to a heterozygous advantage model of inheritance as it was overrepresented in the control participants (p = 0.009). In sex specific analysis the protective association persisted in male participants (p = 0.016) but not in females. Unlike the rs2779249 variant, the rs2248814 variant was not associated with Achilles tendinopathy or Achilles tendon rupture.ConclusionThe rs2779249 CA genotype within the human iNOS gene appears to protect individuals from Achilles tendinopathy. This study further supports a genetic contribution to modifying the risk of Achilles tendon problems. The study also infers an important role for nitric oxide in tendon healing and/or degradation. 相似文献
5.
6.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(12):2883-2889
Background and aimsCoronary artery disease (CAD) is the principal cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use genetic epidemiology to study the association between de novo lipogenesis (DNL), one of the major pathways leading to NAFLD, and CAD risk.Methods and resultsDNL susceptibility genes were used as instruments and selected using three approaches: 1) genes that are associated with both high serum triglycerides and low sex hormone-binding globulin, both downstream consequences of DNL (unbiased approach), 2) genes that have a known role in DNL (biased approach), and 3) genes that have been associated with serum fatty acids, used as a proxy of DNL. Gene-CAD effect estimates were retrieved from the meta-analysis of CARDIoGRAM and the UK Biobank (~76014 cases and ~264785 controls). Effect estimates were clustered using a fixed-effects meta-analysis. Twenty-two DNL susceptibility genes were identified by the unbiased approach, nine genes by the biased approach and seven genes were associated with plasma fatty acids. Clustering of genes selected in the unbiased and biased approach showed a statistically significant association with CAD (OR:1.016, 95%CI:1.012; 1.020 and OR:1.013, 95%CI:1.007; 1.020, respectively), while clustering of fatty acid genes did not (OR:1.004, 95%CI:0.996–1.011). Subsequent exclusion of potential influential outliers did reveal a statistically significant association (OR:1.009, 95%CI:1.000; 1.018).ConclusionsDNL susceptibility genes are associated with an increased risk of CAD. These findings suggest that DNL may be involved in the pathogenesis of CAD and favor further development of strategies that target NAFLD through DNL. 相似文献
7.
《Brain & development》2022,44(3):244-248
BackgroundPyruvate dehydrogenase complex (PDHC) deficiency is an inborn error of metabolism that causes lactic acidosis and neurodevelopmental changes. Five causative genes have been identified: PDHA1, PDHB, DLAT, DLD, and PDHX. Four neurological phenotypes have been reported: neonatal encephalopathy with lactic acidosis, non-progressive infantile encephalopathy, Leigh syndrome, and relapsing ataxia. Of these, neonatal encephalopathy has the worst mortality and morbidity and there is no effective treatment.Subjects and methodsWe studied two girls who were clinically diagnosed with PDHC deficiency as neonates; they were subsequently found to have PDHA1 mutations. The clinical diagnosis was based on white matter loss and a lateral ventricular septum on fetal MRI, spasticity of the lower extremities, and lactic acidosis worsening after birth. Intravenous ketogenic diets were started within 24 h after birth. The ketogenic ratio was increased until the blood lactate level was controlled, while monitoring for side effects.ResultsIn both cases, the lactic acidosis improved immediately with no apparent side effects. Both children had better developmental outcomes than previously reported cases; neither exhibited epilepsy.ConclusionsIntravenous ketogenic diet therapy is a treatment option for neonatal-onset PDHC deficiency. Further studies are needed to optimize this therapy. 相似文献
8.
New generation sequencing (NGS) genetic testing is a powerful diagnostic tool and is increasingly used in the clinical workup of patients, especially in unusual presentations or where a positive family history suggests heritable disease. This review addresses the NGS technologies Targeted sequencing (TS), Whole exome sequencing (WES), Whole genome sequencing (WGS), and the use of gene panels or gene lists for clinical diagnostic purposes. These methods primarily assess nucleotide sequence but can also detect copy number variants and many tandem repeat expansions, greatly simplifying diagnostic algorithms for movement disorders. Studies evaluating the efficacy of NGS in diagnosing movement disorders have reported a diagnostic yield of up to 10.1% for familial and 15.7% for early-onset PD, 11.7–37.5% for dystonia, 12.1–61.8% for ataxia/spastic paraplegia and 11.3–28% for combined movement disorders. Patient selection and stringency in the interpretation of the detected variants and genotypes affect diagnostic yield. Careful comparison of the patient's or family's disease features with the previously reported phenotype associated with the same variant or gene can avoid false-positive diagnoses, although some genes are implicated in various phenotypes. Moving from TS to WES and WGS increases the number of patients correctly diagnosed, but for many patients, a genetic cause cannot be identified today. However, new genetically defined entities are discovered at rapid pace, and genetic databases and our knowledge of genotype-phenotype correlations expand steadily. We discuss the need for clear communication of genetic results and suggest a list of aspects to consider when reporting neurogenetic disorders using NGS testing. 相似文献
9.
10.